Imaging & AI
Tempus Announces FDA Clearance for ECG-MR, an AI Tool Flagging Possible Undiagnosed Mitral Regurgitation
Tempus says its ECG software for flagging possible undiagnosed mitral regurgitation is cleared, but the announcement gives no accuracy figures, launch date, or reimbursement details that imaging teams and health systems would need to plan.
